A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/26 (2006.01) A61K 47/28 (2006.01) A61K 47/48 (2006.01) A61K 31/713 (2006.01)
Patent
CA 2708153
The present invention provides iRNA agents comprising at least one subunit of the formula (I): wherein: A and B are each independently for each occurrence O, N(R N) or S; X and Y are each independently for each occurrence H, OH, a hydroxyl protecting group, a phosphate group, a phosphodiester group, an activated phosphate group, an activated phosphite group, a phosphoramidite, a solid support, -P(Z')(Z")0- nucleoside, -P(Z')(Z")O- oligonucleotide, a lipid, a PEG, a steroid, a lipophile, a polymer, -P(Z')(Z")O-Linker-OP(Z"')(Z"")O-oligonucleotide, a nucleotide, an oligonucleotide, - P(Z')(Z")-formula(I), -P(Z')(Z")- or -Linker-R; R is L G, -Linker-L G, or has the structure shown below: L G is independently for each occurrence a carbohydrate, e.g., monosaccharide, disaccharide, trisaccharide, tetrasaccharide, oligosaccharide, polysaccharide; R N is independently for each occur- remce H, methyl, ethyl, propyl, isopropyl,butyl, or benzyl; and Z', Z", Z"' and Z are each independently for each occurrence O or S.
La présente invention concerne des agents ARNi qui comprennent au moins une sous-unité de formule (I) (liant) dans laquelle : A et B représentent chacun indépendamment pour chaque occurrence O, N(RN) ou S; X et Y représentent chacun indépendamment pour chaque occurrence H, OH, un groupe protecteur hydroxyle, un groupe phosphate, un groupe phosphodiester, un groupe phosphate activé, un groupe phosphite activé, un phosphoramidite, un support solide, -P(Z')(Z")0- nucléoside, -P(Z' )(Z")O-oligonucléotide, un lipide, un PEG, un stéroïde, un lipophile, un polymère, -P(Z' )(Z")O-liant-OP(Z'")(Z"")O-oligonucléotide, un nucléotide, un oligonucléotide, - P(Z')(Z")-formule(I), -P(Z' )(Z")- ou -liant-R; R représente LG, -liant-LG, ou présente la structure illustrée ci-dessous (voir structure) : LG représente indépendamment pour chaque occurrence un glucide, par exemple, un monosaccharide, un disaccharide, un trisaccharide, un tétrasaccharide, un oligosaccharide, un polysaccharide; RN représente indépendamment pour chaque occurrence H, méthyle, éthyle, propyle, isopropyle, butyle, ou benzyle; et Z', Z", Z"' et Z"" représentent chacun indépendamment pour chaque occurrence O ou S.
Maier Martin
Manoharan Muthiah
Narayanannair Jayaprakash K.
Rajeev Kallanthottathil G.
Alnylam Pharmaceuticals Inc.
Riches Mckenzie & Herbert Llp
LandOfFree
Carbohydrate conjugates as delivery agents for oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbohydrate conjugates as delivery agents for oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbohydrate conjugates as delivery agents for oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1816108